Rankings
▼
Calendar
GERN Q1 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$304,000
+1347.6% YoY
Gross Profit
$304,000
100.0% margin
Operating Income
-$56M
-18465.1% margin
Net Income
-$55M
-18220.4% margin
EPS (Diluted)
$-0.09
QoQ Revenue Growth
+1221.7%
Cash Flow
Operating Cash Flow
-$62M
Free Cash Flow
-$63M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$482M
Total Liabilities
$137M
Stockholders' Equity
$345M
Cash & Equivalents
$190M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$304,000
$21,000
+1347.6%
Gross Profit
$304,000
$21,000
+1347.6%
Operating Income
-$56M
-$40M
-40.0%
Net Income
-$55M
-$38M
-45.3%
← FY 2024
All Quarters
Q2 2024 →